No medicines have been found.
As monotherapy for the treatment of adults with unresectable locally advanced or metastatic human epidermal growth factor receptor 2 (HER2) positive (IHC3+) biliary tract cancer (BTC) previously treated with at least 1 prior line of systemic therapy.
